Immtech Pharmaceuticals, Inc. (Amex: IMM) has announced that the State Food and Drug Administration of the People's Republic of China (SFDA) has granted Immtech's application Fast Track Status for conducting a Phase III clinical trial with pafuramidine, the company's oral drug candidate for the ...